• Explore /
  • Poster
  • / Development of a composite biomarker-based calculator to predict the probability of pathologic complete response (pT0) after neoadjuvant pembrolizumab (pembro) in muscle invasive bladder cancer (MIBC).

Development of a composite biomarker-based calculator to predict the probability of pathologic complete response (pT0) after neoadjuvant pembrolizumab (pembro) in muscle invasive bladder cancer (MIBC).

Abstract Poster

Authors

Andrea Necchi

Andrea Necchi

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Andrea Necchi , Joshua J. Meeks , Marco Bandini , Leigh Ann Fall , Daniele Raggi , Alberto Briganti , Elena Farè , Patrizia Giannatempo , Kimberly A. McLaughlin , Arighno Das , Laura Marandino , Andrea Gallina , Andrea Salonia , Giorgio Gandaglia , Nicola Fossati , Jeffrey S. Ross , Francesco Montorsi , Ryan Dittamore , Elai Davicioni , Ewan Gibb

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Translational Research

Clinical Trial Registration Number

NCT02736266

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 539)

Abstract #

539

Poster Bd #

K20

Abstract Disclosures

Similar Posters

First Author: Michael Lattanzi

First Author: Matt D. Galsky

First Author: Chiara Mercinelli

First Author: Andrea Necchi